Osteopontin and Clinical Outcomes in Hemodialysis Patients

Osteopontin and Clinical Outcomes in Hemodialysis Patients

Background/Objectives: Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) are significant public health issues, with cardiovascular morbidity and mortality being the leading causes of death in hemodialysis patients. Osteopontin (OPN), a multifunctional glycoprotein, has emerged as a po...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudia Torino, Federico Carbone, Patrizia Pizzini, Sabrina Mezzatesta, Graziella D’Arrigo, Mercedes Gori, Luca Liberale, Margherita Moriero, Cristina Michelauz, Federica Frè, Simone Isoppo, Aurora Gavoci, Federica La Rosa, Alessandro Scuricini, Amedeo Tirandi, Davide Ramoni, Francesca Mallamaci, Giovanni Tripepi, Fabrizio Montecucco, Carmine Zoccali
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomedicines
Subjects:
OPN
hemodialysis
clinical outcomes
cardiovascular
mineral metabolism
biomarker
Online Access:https://www.mdpi.com/2227-9059/12/11/2605
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items